You searched for "litigation"
Haag-Streit UK launch a new e-shop
18 December 2023
|
Company Profiles, Research & Development
Haag-Streit UK is pleased to announce the launch of a brand new e-shop at https://eshopuk.haag-streit.com/
Stem cell therapy for Parkinson’s disease: researching for an effective cure
1 December 2015
| Romina Vuono
|
EYE - Neuro-ophthalmology
Neurodegenerative diseases are characterised by the chronic and progressive loss of neurons, which in turn results in loss of cognitive and physical functions. The World Health Organization has estimated that the disability-adjusted life years lost from neurological disease was about...
Art in Motion
5 June 2023
| Rahila Bashir, Nick Astbury
|
EYE - General
One sunny Thursday afternoon, in the spring of March 2023, I was invited to attend a zoom call with Nick Astbury, who works part-time at the International Centre for Eye Health at the London School of Hygiene & Tropical Medicine....
Thomas Truckenbrod awarded for his outstanding contribution to the optical profession
The International Opticians Association (IOA) has given Thomas Truckenbrod a special award recognising his outstanding contribution to the optical profession. The award was presented by IOA director of development Elaine Grisdale at the SILMO d’Or ceremony on Saturday 30 September in Paris.Risk of intraocular haemorrhage with new oral anticoagulants
1 December 2017
| Sofia Rokerya
|
EYE - Vitreo-Retinal
The authors conducted a study to assess the risk of intraocular haemorrhage with warfarin dabigatran, rivaroxaban, apixaban. All reported cases of intraocular haemorrhage (vitreous, choroidal, or retinal) with warfarin and new oral anticoagulants (NOACs) (including dabigatran, rivaroxaban, apixaban) from the...
Sensorimotor outcomes following paediatric ocular trauma
A retrospective assessment of sensorimotor outcomes was conducted in paediatric patients after ocular trauma to evaluate potential predictors of poor outcome including time of treatment deprivation, Paediatric Ocular Trauma score (POTS) and patient characteristics. The review was from 2006-2020 and...A lifelong commitment to ophthalmology
28 May 2025
|
Company Profiles
Altomed is the largest independent supplier to the UK ophthalmic surgical sector. We manufacture and distribute over 3,000 high-quality products, including reusable instruments, single use devices and consumables, sterilisation trays, implants, liquids and gases and simulation training models. Altomed are...
UKISOP and the allied health professions
3 April 2024
| Rebecca Turner
|
EYE - General
In ophthalmology practice today there is a vast number of training and educational opportunities for staff from all professional backgrounds. The key is to use your study leave and funding wisely! In the first of this series of articles, signalling...
Long-term outcome of ALPI for plateau iris syndrome
1 April 2018
| Chrysostomos D Dimitriou
|
EYE - Glaucoma
The purpose of this study was to evaluate the long-term outcomes of plateau iris syndrome (PIS) patients treated with argon laser peripheral iridoplasty (ALPI) following YAG laser peripheral iridotomy (LPI). Typical ALPI settings were a spot size of 200 to...
Mast cells in Graves’ ophthalmopathy
1 August 2016
| Bheemanagouda Patil
|
EYE - General
Graves’ ophthalmopathy (GO) is a potentially sight-threatening ocular disease, occurring in patients with hyperthyroidism due to Graves’ disease. Also known as thyroid-associated ophthalmopathy, GO is characterised by orbital infiltration by immune cells including macrophages, T cells and plasma cells, which...
Choroidal and RNFL thickness in patients with OSAS
1 August 2015
| Anjali Gupta
|
EYE - Vitreo-Retinal
In obstructive sleep apnoea syndrome (OSAS), hypoxia secondary to repetitive apnoeic episodes leads to blood pressure variations and haemodynamic changes. There is also intermittent activation of the sympathetic system when the patient is aroused from sleep during apnoeic episodes. OSAS...